CardioNet Restructures and Expands Medical Advisory Board.CONSHOHOCKEN, Pa. -- CardioNet, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the restructuring and expansion of its Medical Advisory Board (MAB). The Company added six new members and retained two original members, bringing the current size of the MAB to eight. CardioNet's MAB is comprised of leading clinicians and researchers in the fields of cardiology, electrophysiology, thoracic surgery and neurology who advise the Company on its clinical programs and provide strategic guidance to support the commercial adoption of CardioNet's Mobile Cardiac Outpatient Telemetry[TM] (MCOT[TM]). Peter R. Kowey, M.D., Medical Director and Chairman of CardioNet's Medical Advisory Board, said, "The CardioNet Medical Advisory Board is a highly talented group of physicians. Their diverse expertise will help us to continue to advance the technology beyond what CardioNet is today, to benefit even more patients with cardiovascular disease. I am excited to chair this extraordinary group." Randy Thurman, Chairman, President and Chief Executive Officer of CardioNet, said, "We are very pleased to welcome the new members of our Medical Advisory Board. Our Medical Advisory Board will be instrumental in the achievement of CardioNet's strategic imperatives as well as our mission to become the leader in wireless medicine. The MAB will not only enhance our strategies with respect to MCOT, but it will also contribute significantly as we explore adjacent markets to expand our current business and work with us to integrate new therapeutic and diagnostic modalities into our platform technology. The addition of these new members to our Medical Advisory Board is further reinforcement of CardioNet's leadership position in mobile cardiac outpatient telemetry and a clear reflection of the company's potential. CardioNet is honored to welcome this extraordinarily accomplished group of physicians and scientists to the company." CardioNet's Medical Advisory Board is comprised of the following members: Peter R. Kowey, M.D., FACC FACC Fellow, American College of Cardiology , FACP FACP Fellow of the American College of Physicians. FACP abbr. 1. Fellow of the American College of Physicians 2. Fellow of the American College of Prosthodontists , FACCP FACCP abbr. Fellow of the American College of Chest Physicians FACCP Fellow, American College of Chest Physicians , FCP - Medical Director and Chairman of the Medical Advisory Board Dr. Kowey joined CardioNet as its Medical Director in 2002 and was named Chairman of the MAB in March, 2009. He is Chief of the Division of Cardiovascular Diseases for the Main Line Health System, including Lankenau Hospital. He is also Professor of Medicine and Clinical Pharmacology at Jefferson Medical College, and President of the Heart Center of the Main Line Health System. He has served as a member of the Cardiorenal Drug Advisory Committee and the Cardiovascular Devices Committee of the U.S. Food and Drug Administration and holds the William Wikoff Smith Chair in Cardiovascular Research. Dr. Kowey received his medical degree from the University of Pennsylvania School of Medicine The University of Pennsylvania's School of Medicine, presently located in the University City section of Philadelphia, Pennsylvania, was the United States's first school of medicine, founded at the College of Philadelphia, as the University was then called. . David G. Benditt, M.D., FACC, FRCP FRCP Fellow of the Royal College of Physicians. FRCP abbr. Fellow of the Royal College of Physicians (C), FHRS Dr. Benditt is Professor of Medicine and Co-Director of the Cardiac Arrhythmia and Syncope syncope Effect of temporary impairment of blood circulation to a part of the body. It is often used as a synonym for fainting, which is loss of consciousness due to inadequate blood flow to the brain. Center at University of Minnesota Medical School The University of Minnesota Medical School is the medical school of the University of Minnesota. It is a combination of two campuses situated in Minneapolis and Duluth, Minnesota. . Dr. Benditt is a past president of the North American Society for Pacing and Electrophysiology (now known as the Heart Rhythm Society). He currently is an Associate editor with the Journal of Interventional Electrophysiology (JICE) and is an editorial board member of the Journal of the American College of Cardiology The American College of Cardiology (ACC) is a nonprofit medical association established in 1949 to educate, research and influence health care public policy. The president for the 2006–2007 year is Steven E. Nissen. [1] The organization has 39 chapters in the U.S. (JACC), Europace, and the American Journal of Cardiology (AJC). Dr. Benditt received his medical degree from the University of Manitoba Location The main Fort Garry campus is a complex on the Red River in south Winnipeg. It has an area of 2.74 square kilometres. More than 60 major buildings support the teaching and research programs of the university. . Kenneth A. Ellenbogen, M.D., FACC Dr. Ellenbogen is the Vice-Chairman of Cardiology at Virginia Commonwealth University Formed by a merger between the Richmond Professional Institute and the Medical College of Virginia in 1968, VCU has a medical school that is home to the nation's oldest organ transplant program. (VCU) and was awarded the Kontos Endowed Professorship in 2000. He also serves as Director of Clinical Cardiac Electrophysiology Cardiac Electrophysiology (also referred to as clinical cardiac electrophysiology , Arrhythmia Services , or electrophysiology), is a branch of the medical specialty of cardiology/cardiac surgery concerned with the study and treatment of rhythm disorders of the and Pacing at both VCU's MCV Campus and the McGuire Veterans Administration Medical Center. Dr. Ellenbogen serves on the editorial boards of the Journal of the American College of Cardiology, American Journal of Cardiology, American Heart Journal, Circulation, the Journal of Cardiovascular Electrophysiology, Heart Rhythm and is one of the Senior Editors of PACE. Dr. Ellenbogen received his medical degree from Johns Hopkins University Johns Hopkins University, mainly at Baltimore, Md. Johns Hopkins in 1867 had a group of his associates incorporated as the trustees of a university and a hospital, endowing each with $3.5 million. Daniel C. . Scott Eric Kasner, M.D., MSCE, FAHA Dr. Kasner is Associate Professor of Neurology and Director of the Comprehensive Stroke Center at the Hospital of the University of Pennsylvania (body, education) University of Pennsylvania - The home of ENIAC and Machiavelli. http://upenn.edu/. Address: Philadelphia, PA, USA. . He is a member of the leadership committee of the American Stroke Association and is on the editorial board of the Journal of Stroke and Cerebrovascular Disease, as well as the stroke section editor of UpToDate. Dr. Kasner received his medical degree from Yale Medical School. Arthur J. Moss, M.D. Dr. Moss is Professor of Medicine (Cardiology) and Professor of Community and Preventive Medicine at University of Rochester The University of Rochester (UR) is a private, coeducational and nonsectarian research university located in Rochester, New York. The university is one of 62 elected members of the Association of American Universities. School of Medicine and Dentistry. He is also the Director of the Heart Research Follow-up Program at the University of Rochester Medical Center The University of Rochester Medical Center (URMC), located in Rochester, New York, is one of the main campuses of the University of Rochester and comprises the university's primary medical education, research and patient care facilities. and Editor-in-Chief for the Annals of Noninvasive Electrocardiology. Dr. Moss received his medical degree from Harvard Medical School Harvard Medical School (HMS) is one of the graduate schools of Harvard University. It is a prestigious American medical school located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts. . Evelio Rodriguez, M.D., FACS FACS Fellow of the American College of Surgeons. FACS abbr. Fellow of the American College of Surgeons FACS fluorescence-activated cell sorter. Dr. Rodriguez is a practicing cardiothoracic surgeon at the Brody School of Medicine, East Carolina University East Carolina University is a public, coeducational, intensive research university located in Greenville, North Carolina, United States. Named East Carolina University by statue and commonly known as ECU or East Carolina , where he is Assistant Professor of Surgery and Pediatrics in the Department of Cardiovascular Sciences. Dr. Rodriguez received his medical degree from Albany Medical College. Philip Sager, M.D., FACC, FAHA, FHRS Dr. Sager is Chief Medical Officer of CardioDx, Inc., a privately-held cardiovascular genomic diagnostics company based in Palo Alto, CA. He is Co-Chair of the Scientific Oversight Committee and Executive Committee member of the FDA-sponsored Cardiac Safety Research Consortium. He is also a member of the International Committee on Harmonization (ICH E14 Implementation Group). Dr. Sager received his medical degree from Yale School of Medicine The primary teaching hospital for the school is Yale-New Haven Hospital. The school is home to the Harvey Cushing/John Hay Whitney Medical Library, one of the largest modern medical libraries, also known for its historical collections. . William S. Weintraub, M.D., FACC, FAHA Dr. Weintraub is the John H. Ammon Chair of Cardiology at Christiana Care Health System, Professor of Medicine at Jefferson University and Professor of Health Sciences at the University of Delaware. He is also director of the Christiana Center for Outcomes Research, which focuses on identifying and supporting "best practices" in medicine and improving health care. He is Chairman of the CathPCI Steering Committee for the American College of Cardiology National Cardiovascular Data Registry. Dr. Weintraub received his medical degree from Johns Hopkins University. About CardioNet, Inc. CardioNet is the leading provider of ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health. CardioNet's initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, with a solution that it markets as Mobile Cardiac Outpatient Telemetry[TM] (MCOT[TM]). More information can be found at http://www.cardionet.com. Forward Looking Statements This press release includes certain forward-looking statements within the meaning of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 regarding, among other things, our growth prospects, the prospects for our products and our confidence in the Company's future. These statements may be identified by words such as "expect", "anticipate", "estimate", "project", "intend", "plan", "believe", and other words and terms of similar meaning. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including important factors that could delay, divert, or change any of them, and could cause actual outcomes and results to differ materially from current expectations. These factors include, among other things, the success of our sales and marketing initiatives, our ability to attract and retain talented sales personnel, the commercialization of new products, market factors, internal research and development initiatives, partnered research and development initiatives, competitive product development, changes in governmental regulations and legislation, changes to reimbursement levels for our products, the continued consolidation of payors, acceptance of our new products and services and patent protection and litigation. For further details and a discussion of these and other risks and uncertainties, please see our public filings with the Securities and Exchange Commission, including our latest periodic report on Form 10-K or 10-Q. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. |
|
|||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion